LGD-6972

N/A

Report date: 2024/08/13 15:18:35
NME

Base Information

Drug NameLGD-6972
Drug Alias NameLGD-6972 sodium saltCompound HCpd HCpd GGCGR Antagonist Program - Ligand Pharmaceuticals +[9] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon receptor antagonists
TargetsGlucagon receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLigand Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A